The incidence of severe hypoglycemia was 1.3% in the liraglutide group and 1.5% in the placebo group, revealing that although the risk of low blood sugar levels is normally modest with GLP-1-RAs, care should be taken when taking these drugs in conjunction with other glucose-lowering therapies that are known to induce hypoglycemia [79]. Here, GCG is linked to Hypoglycemia.